The Cydan Team
Cristina Csimma, PharmD, MHP
Founder, Director and Advisor
Dr. Csimma was the founding CEO of Cydan. Prior to Cydan she worked in advisory roles with biopharmaceutical and venture capital firms, was Vice President, Drug Development at Virdante Pharmaceuticals Inc. and was a Principal at Clarus Ventures LLC. Previously, she held roles in Clinical Research and Translational Medicine at Wyeth and Genetics Institute. Her global development experience encompasses multiple therapeutic areas including rare diseases, exploratory through registration clinical programs and integration of biomarkers and novel technologies into development. She started her career as a clinical pharmacist at the Dana Farber Cancer Institute.
Dr. Csimma serves on the board of directors of Columbia Labs Inc., and is a member of the MDA’s Scientific Development Advisory Committee; the external oversight board to the NIH NINDS NeuroNext (Network for Excellence in Neuroscience Clinical Trials); the TREAT-NMD Advisory Committee for Therapeutics (TACT) (former chair), and Northeastern University’s Health Sciences Entrepreneurs program steering committee.
Dr. Csimma received her Bachelor of Science and Doctor of Pharmacy degrees from Massachusetts College of Pharmacy, and a Master of Health Professions from Northeastern University.